Skip to content
Screener

Axogen AXGN Investing Cash Flow

Investing Cash Flow at other companies

Baxter International logo
Baxter InternationalBAX
-$133M-104%
Stryker logo
StrykerSYK
-$639M-514%
IAR
Integra LifeSciencesIART
-$43.28M-99.9%
LeMaitre Vascular logo
LeMaitre VascularLMAT
-$11.08M+32.2%
Artivion logo
ArtivionAORT
-$129.41M-3,837%
Bioventus logo
BioventusBVS
-$2.46M-79.7%

Other financials

Income statement

See full
Revenue$69.7M+23.1%
Gross profit$50.7M+20.6%
Operating income-$2.2M-229%
Net income-$1.5M-362%
EPS (diluted)-$0.03-400%

Balance sheet

See full
Cash & equivalents$96.6M+271%
Total debt$20.1M-70.6%
Total equity$256.3M+128%
Total assets$304.9M+48.4%

Cash flow

See full
Operating cash flow$7.2M
CapEx$893.0K+23.7%
Free cash flow$6.3M

Valuation

See full
Market cap$2.38B+277%
Enterprise value$2.31B+242%
P/S9.5×+6.4×

Profitability

See full
Gross margin74.6%+0.3pp
Operating margin-5.1%
Net margin-13.4%-17.4pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18.2%-28.9pp
Debt / equity0.1×-0.5×
Current ratio6.6×+2.5×

Where this comes from

Reported directly by Axogen in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Axogen’s 10-Q, filed April 28, 2026.

Filed
Apr 28, 2026, 4:04 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000805928-26-000053
Line itemThree Months Ended / March 31,2026Three Months Ended / March 31,2025
Purchase of investments(19,000)
Proceeds from sale of investments6,0002,000
Cash payments for intangible assets(175)(405)
Net cash (used in) provided by investing activities(15,964)1,339
Cash flows from financing activities:
Proceeds from issuance of common stock134,044
Payment of stock issuance costs(792)
Repayment of long-term debt(48,585)

ITEM 1 — FINANCIAL STATEMENTS

FAQ

What is Axogen's investing cash flow?
Axogen (AXGN) reported investing cash flow of -$15.96M in Q1 2026.
How has Axogen's investing cash flow changed year-over-year?
Axogen's investing cash flow decreased by 1292.2% year-over-year, from $1.34M to -$15.96M.
What is the long-term trend for Axogen's investing cash flow?
Over 2 years (2021 to 2024), Axogen's investing cash flow has grown at a -34.0% compound annual growth rate (CAGR), from -$23.65M to -$10.3M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Axogen's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude